GlassScriptPhysician profile
David Addison Miles
NPI 1477542223
$3,897.32
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,129 · 2020: $640 · 2021: $277 · 2022: $1,070 · 2023: $659 · 2024: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $736.59 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $646.82 | 2019-2023 | |
| Amgen INC. | $428.52 | 2019-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $353.85 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $322.35 | 2019-2022 | |
| Astellas Pharma US INC | $187.80 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $184.98 | 2019-2022 | |
| Pfizer INC. | $172.99 | 2019-2023 | |
| Boston Scientific Corporation | $112.00 | 2021-2023 | Watchman Access System, Watchman |
| Merck Sharp & Dohme LLC | $111.33 | 2021-2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $105.03 | 2019-2023 | |
| Actelion Pharmaceuticals US, INC. | $89.61 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.15 | 2019-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $77.28 | 2019-2022 | |
| Amarin Pharma, INC. | $58.50 | 2019-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $40.13 | 2021 | |
| Akcea Therapeutics, INC. | $36.04 | 2019 | |
| Gilead Sciences, INC. | $35.62 | 2019 | |
| Portola Pharmaceuticals, LLC | $30.56 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.00 | 2022-2023 | |
| Lundbeck LLC | $22.78 | 2019 | |
| Ge Healthcare | $15.38 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.